San Diego, CA, United States of America

David Robert Slochower

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Robert Slochower: Innovator in Pain Treatment

Introduction

David Robert Slochower is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain. His innovative work has led to the development of compounds that have the potential to improve the quality of life for many individuals suffering from various disorders.

Latest Patents

David Robert Slochower holds 1 patent for his invention titled "Heteroaryl compounds for the treatment of pain." This patent encompasses compounds and pharmaceutically acceptable salts that serve as inhibitors of sodium channels. The invention also includes pharmaceutical compositions that utilize these compounds, along with methods for their application in treating pain and other related disorders.

Career Highlights

Slochower is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company. His role at Vertex has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

One of his notable coworkers is Dennis James Hurley. Together, they have worked on advancing the understanding and treatment of pain through innovative pharmaceutical solutions.

Conclusion

David Robert Slochower's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in pain management. His contributions continue to pave the way for new treatments that can benefit countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…